Nitin Lath

Nitin Lath

Managing Director

Mumbai Office  |   |   +91 22-6127-1191

Nitin Lath, a Managing Director in Torreya’s Mumbai office, has two decades of investment banking experience analyzing and advising Indian companies across all life sciences sectors.

Before joining Torreya in 2016, Nitin led the healthcare banking division of IDFC Securities and was a member of life sciences investment banking teams at Avendus Capital and Yes Bank Ltd. Earlier in his career, while at IDBI Bank Ltd., he was responsible for the life sciences credit portfolio, and he was a member of the structured finance team at ICICI Bank Ltd.

Highlights of Nitin’s life sciences transaction work include advising Dr. Reddy’s on its acquisition of drug-delivery company Octoplus, advising Shasun Pharma in its merger with Strides, advising Greater Pacific Capital on the sale of its stake in Torrent, and advising Bain Capital on its acquisition of Blackstone’s stake in Emcure Pharma.

Nitin earned his B.A in commerce from Mumbai University. He is also a Chartered Accountant from ICAI and a Chartered Financial Analyst. Nitin is fluent in English and Hindi.

Selected Transactions

Rubicon Research
Majority recap by
General Atlantic Partners
$125 million
April 2019
BE Vaccines SAS sale to Clean Cells, a portfolio company of
March 2019
Motilal Oswal
purchase of majority stake in
December 2018
Neuland Laboratories
Acquisition of
API facility from
Arch Pharma
December 2017
Neuland Laboratories
Sale of stake of
$35 million
Joint Sell-Side Advisor
May 2017
Sale of selected
generic brands to
Samara Capital
June 2017
Sale of India women's health business to
Torrent Pharma
April 2017
Rubicon Research
Sale of equity stake to
Everstone Group
$33 million
November 2016